Design of BET Inhibitor Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities
暂无分享，去创建一个
Matthew R. Golder | M. Shipitsin | B. Vangamudi | S. Huh | P. Blume-Jensen | E. de Stanchina | O. Burenkova | S. Paramasivan | M. Jessel | Jeremiah A. Johnson | D. Chickering | J. Baddour | W. Dahlberg | K. Economides | James C. Ackley | P. Kopesky | Jannik N Andersen | H. Nguyen | P. Shieh | Jenny Liu | L. A. Reiter | Farrukh Vohidov | D. Turnquist | N. Gallagher | Deborah J. C. Ehrlich | Julie Kim | Allison M. Neenan | Gaurab Kc | Samantha W. Brady | Jennifer K. Saucier-Sawyer | M.J. Jessel | Joelle A Baddour | Kyriakos D. Economides | Nolan M. Gallagher | David J. Turnquist